• We know what we know – and that comes
from the past
we have to cope with that
• Comparative data on toxicity and QoL of RT vs
adjuvant hormonal treatment are lacking
• Our “feelings” on risks and treatment benefits
probably need to be adapted
• What’s new tomorrow will be challenged again
~ possibly outdated after tomorrow
Less local treatment: conclusions